Xu, Peng
Li, Siyang
Liu, Ke
Fan, Rui
Liu, Fahui
Zhang, Haoxuan
Liu, Donghua
Shen, Dongyan
Funding for this research was provided by:
National Natural Science Foundation of China (82270664)
Project of Xiamen Cell Therapy Research, Xiamen, Fujian, China (3502Z20214001)
Article History
Received: 29 September 2023
Accepted: 9 November 2023
First Online: 1 February 2024
Declarations
:
: The authors declare no conflicts of interests.
: The studies involving human participants were reviewed and approved by the Ethics Committees of The First Affiliated Hospital of Xiamen University (Xiamen, China) (The IRB approval number: XMYY-2022KYSB003).
: All study participants gave their informed consent after being fully informed. The patients have given their written, informed consent for this paper's publication.